Since HCCFA, MK204, and oleanolic acid are commercially available, they can be used for elucidating the mechanisms underlying tumorigenesis of AKR1B10-overexpressing cancers and chemotherapy resistance, which would precede AKR1B10-based therapies in clinical cancer management. This evidence concerns the gene AKR1B10 and cancer.